Predictive value of relative changes in serum total sialic acid level for response to neoadjuvant chemotherapy in patients with locally advanced breast carcinoma

Neoplasma

Volumn 53, Issue 4, 2006, Pages 347-351

  Celen, O ^a   Yildirim, E ^a   Ozen, N ^a   Sonmez, C ^a  

^a ANKARA ONCOLOGY EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Breast carcinoma; Neoadjuvant chemotherapy; Response; Sialic acid

Indexed keywords

SIALIC ACID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLOOD ANALYSIS; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; HUMAN; MASTECTOMY; PATHOLOGY; PREOPERATIVE CARE; SENSITIVITY AND SPECIFICITY;

EID: 33746273220     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. DREW PJ, KERIN MJ, MAHAPATRA T, MALONE C, MONSON JRT et al. Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 2001; 27: 617-620.
2. KUERER HM, NEWMAN LA, BUZDAR AU, HUNT KK, DKINGRA K et al. Residual metastatic axillary lymph nodes following neoadjuvant chemotherapy predict disease-free survival in patients with locally advanced breast cancer. Am J Surg 1998; 176: 502-509.
3. WINER EP, MORROW M, OSBORNE CK, HARRIS JR. Malignant tumors of the breast. In DeVita VT, Hellman S, Rosenberg SA, editors. Cancer Principles and Practice of Oncology. Philadelphia: Lippincott Williams&Wilkins, 2001: 1697-1698.
4. KRIAT M, VION-DURY J, FAVRE R, MARANINCHI D, HARLE JR et al. Variations of plasma sialic acid and N-acetylglucosamine levels in cancer, inflammatory diseases and bone marrow transplantation: a proton NMR spectroscopy study. Biochimie 1991; 73: 99-104.
5. MALYKH YN, SCHAUER R, SHAW L. N-glycolylneuraminic acid in human tumours. Biochimie 2001; 83: 623-634.
6. SONMEZ H, SUER S, GUNGOR Z, BALOGLU H, KOKOGLU E. Tissue and serum sialidase levels in breast cancer. Cancer Lett 1999; 136: 75-78.
7. GREENE FL, PAGE DL, FLEMING ID, FRITZ AG, BALCH CM et al (eds). American Joint Committee on Cancer, Cancer Staging Manual. New York: Springer-Verlag, 2002: 223-240.
8. MILLER AB, HOOGSTRATEN B, STAQUET M, WINKLER A. Reporting results of cancer treatment. Cancer 1981; 47: 207-214.
9. CROOK M. The determination of plasma or serum sialic acid. Clin Biochem 1993; 26: 31-38.
10. YILDIRIM E, SEMERCI E, BERBEROGLU U. The analysis of prognostic factors in stage III-B non-inflammatory breast cancer. Eur J Surg Oncol 2000; 26: 34-38.
11. ELTAHIR A, HEYS SD, HUTCHEON AW, SARKAR TK, WALKER LG et al. Treatment of large and locally advanced breast cancers using neoadjuvant chemotherapy. Am J Surg 1998; 175: 127-132.
12. RESNICK JM, SNEIGE N, KEMP BL, SAHIN A, ORDONEZ NG et al. P53 and c-erbB-2 expression and response to preoperative chemotherapy in locally advanced breast carcinoma. Breast Dis 1995; 8: 149-158.
13. SATALOFF DM, MASON BA, PRESTIPINO AJ. Pathologic response to induction chemotherapy in locally advanced carcinoma of the breast: a determinant of outcome. J Am Coll Surg 1995; 180: 297-306.
14. MACHIAVELLI MR, ROMERO AO, PEREZ JE, LACAVA CA, DOMINGUEZ ME et al. Prognostic significance of pathological response of primary tumour and metastaric axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma. Cancer J Sci Am 1998; 4: 125-131.
15. SUER S, SONMEZ H, KARAASLAN I, BALOGLU H, KOKOGLU E. Tissue sialic acid and fibronectin levels in human prostatic cancer. Cancer Lett 1996; 99: 135-137.
16. WONGKHAM S, BOONLA C, KONGKHAM S, WONGKHAM C, BHUDHISAWASDI V et al. Serum total sialic acid in cholangiocarcinoma patients: an ROC curve analysis. Clin Biochem 2001; 34: 537-541.
17. FEIJOO C, DE LA CADENA MP, RODRIGUEZ-BERROCAL FJ, MARTINEZ-ZORZANO VS. Sialic acid levels in serum and tissue from colorectal cancer patients. Cancer Lett 1997; 112: 155-160.
18. KIMURA Y, FUJIEDA S, TAKABAYASHI T, TANAKA T, SUGIMOTO C et al. Conventional tumor markers are prognostic indicators in patients with head and neck squamous cell carcinoma. Cancer Lett 2000; 155: 163-168.
19. WONGKHAM S, BHUDHISAWASDI V, CHAU-IN S, BOONLA C, MUISUK K et al. Clinical significance of serum total sialic acid in cholangiocarcinoma. Clin ChimActa 2003; 327: 139-147.
20. PASZKOWSKA A, BERBEC H, SEMCZUK A, CYBULSKI M. Sialic acid concentration in serum and tissue of endometrial cancer patients. Eur J Obstet Gyn R B 1998; 76: 211-215.
21. SONMEZ H, KOKOGLU E, SUER S, OZYURT E. Fibronectin and sialic acid levels in human meningiomas and gliomas. Cancer Lett 1995; 90: 119-122.
22. PAINBENI T, GAMELIN E, CAILLEUX A, LE BOUIL A, BOISDRON-CELLE M et al. Plasma sialic acid as a marker of the effect of the treatment on metastatic colorectal cancer. Eur J Cancer 1997; 33: 2216-2220.
23. NARAYANAN S. Sialic acid as a tumor marker. Ann Clin Lab Sci 1994; 24: 376-384.